<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Cai YG</submitter><pubmed_abstract>This study investigated the metabolic profiles of two isomeric psychoactive agents, methyl-ketamine [2-(ortho-tolyl)-2-(methylamino)cyclohexanone] and 2-oxo-PCE [2-(phenyl)-2-(ethylamino)cyclohexanone], in rats. Following oral administration, blood, liver, and urine samples were collected at timed intervals and analyzed via ultrahigh performance liquid chromatography quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS). Metabolomic comparisons revealed distinct metabolic pathways driven by structural differences. Methyl-ketamine primarily underwent cyclohexanone hydroxylation, dehydration, N-demethylation, cyclohexanone carbonyl hydrogenation, and glucuronidation, with N-dealkylation as the dominant process. In contrast, 2-oxo-PCE metabolism involved carbonyl hydrogenation of cycloh</pubmed_abstract><journal>Forensic science international. Synergy</journal><pagination>100623</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12281064</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Metabolic patterns of new psychoactive substances: Methyl-ketamine and 2-oxo-PCE in rats using UHPLC-QTOF analysis.</pubmed_title><pmcid>PMC12281064</pmcid><pubmed_authors>Wu YF</pubmed_authors><pubmed_authors>Wang QH</pubmed_authors><pubmed_authors>Cai YG</pubmed_authors><pubmed_authors>Feng JY</pubmed_authors><pubmed_authors>Dai Y</pubmed_authors><pubmed_authors>Wang YJ</pubmed_authors><pubmed_authors>Mo Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Metabolic patterns of new psychoactive substances: Methyl-ketamine and 2-oxo-PCE in rats using UHPLC-QTOF analysis.</name><description>This study investigated the metabolic profiles of two isomeric psychoactive agents, methyl-ketamine [2-(ortho-tolyl)-2-(methylamino)cyclohexanone] and 2-oxo-PCE [2-(phenyl)-2-(ethylamino)cyclohexanone], in rats. Following oral administration, blood, liver, and urine samples were collected at timed intervals and analyzed via ultrahigh performance liquid chromatography quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS). Metabolomic comparisons revealed distinct metabolic pathways driven by structural differences. Methyl-ketamine primarily underwent cyclohexanone hydroxylation, dehydration, N-demethylation, cyclohexanone carbonyl hydrogenation, and glucuronidation, with N-dealkylation as the dominant process. In contrast, 2-oxo-PCE metabolism involved carbonyl hydrogenation of cycloh</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-03-27T16:22:36.725Z</modification><creation>2025-08-31T03:05:15.794Z</creation></dates><accession>S-EPMC12281064</accession><cross_references><pubmed>40697759</pubmed><doi>10.1016/j.fsisyn.2025.100623</doi></cross_references></HashMap>